Skip to main content
. 2023 May 22;23:229. doi: 10.1186/s12886-023-02959-5

Table 2.

SF-36 characteristics of the study participants

Autoimmune rheumatic patients (n = 90) Controls (n = 30) P Value
Composite score 49.65 ± 20.43 79.66 ± 18.19 < 0.001*
 PCS score 42.34 ± 22.55 81.78 ± 19.11 < 0.001*
 MCS score 56.99 ± 23.73 77.55 ± 19.26 < 0.001*
  PF score 60.56 ± 31.52 94.04 ± 10.10 < 0.001*
  RP score 21.06 ± 37.08 86.54 ± 33.34 < 0.001*
  BP score 50.31 ± 29.45 84.42 ± 21.92 < 0.001*
  GH score 37.44 ± 22.21 62.12 ± 25.85 < 0.001*
  VT score 58.72 ± 21.10 68.85 ± 20.12 0.03*
  SF score 64.86 ± 28.72 88.46 ± 18.34 < 0.001*
  RE score 39.00 ± 45.23 83.33 ± 34.32 < 0.001*
  MH score 64.36 ± 21.34 69.54 ± 18.10 0.26

SF-36 Short Form 36-Health Survey, PCS Physical Component Summary, MCS Mental Component Summary, PF Physical Function, RP Role Physical, BP Body Pain, GH General Hhealth, VT Vitality, SF Social Function, RE Role Emotion, MH Mental Health, n number

P value means autoimmune rheumatic patients compared to controls, *P < 0.05